| 216138 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Prognostic and biologic significance of high LCK expression in ovarian cancer |
2015-11-04 |
10.1186/2051-1426-3-s2-p93 |
Jazaeri Amir, Paquette Cherie, Kelting Sarah M, Stoler Mark H, Zhang Qian, Yates Melinda, Creasy Caitlin, Bernatchez Chantale, Hwu Patrick |
| 216137 |
CURĒUS : MEDICAL KNOWLEDGE FOR THE WORLD |
Computer-Assisted Navigation During an Anterior-Posterior En Bloc Resection of a Sacral Tumor |
2015-11-04 |
10.7759/cureus.373 |
Al Eissa Sami, Al-Habib Amro F, Jahangiri Faisal R |
| 216136 |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
Carbon Fluxes between Primary Metabolism and Phenolic Pathway in Plant Tissues under Stress |
2015-11-04 |
10.3390/ijms161125967 |
Caretto Sofia, Linsalata Vito, Colella Giovanni, Mita Giovanni, Lattanzio Vincenzo |
| 216135 |
NEURO-ONCOLOGY |
Bevacizumab for recurrent primary central nervous system lymphoma: a new treatment? |
2015-11-04 |
10.1093/neuonc/nov246 |
Nieto Karina, Gordon Leo I., Raizer Jeffrey |
| 216134 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Enhanced immunogenicity of a nanoparticle therapeutic cancer vaccine targeting HAAH delivered intradermally using 3M's hollow microstructured transdermal system (hMTS) |
2015-11-04 |
10.1186/2051-1426-3-s2-p433 |
Fuller Steven, Lebowitz Michael, Stewart Solomon, Walker Susan, Ghanbari Hossein, Bohlke Allan, Burton Scott, Chu Leonard, Hua Vinh |
| 216133 |
MATERIALS |
Analysis of Fatigue Crack Paths in Cold Drawn Pearlitic Steel |
2015-11-04 |
10.3390/ma8115388 |
Toribio Jesús, González Beatriz, Matos Juan-Carlos |
| 216132 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Optimizing the delivery of chemotherapy in the setting of immunotherapy in a preclinical glioblastoma model |
2015-11-04 |
10.1186/2051-1426-3-s2-p307 |
Mathios Dimitrios, Kim Jennifer, Phallen Jillian, Mangraviti Antonella, Park Chul-Kee, Theodros Debebe, Jackson Christopher, Garzon-Muvdi Tomas, Kim Eileen, Ye Xiaobu, Tyler Betty, Brem Henry, Pardoll Drew, Lim Michael |
| 216131 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Elevated potassium levels suppress T cell activation within tumors |
2015-11-04 |
10.1186/2051-1426-3-s2-p403 |
Eil Robert L, Roychoudhuri Rahul, Clever David, Patel Shashank, Sukumar Madhu, Pan Jenny H, Palmer Douglas, Klebanoff Christopher A, Restifo Nicholas P |
| 216130 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity |
2015-11-04 |
10.1186/2051-1426-3-s2-p42 |
Anna Pasetto, Gros Alena, Robbins Paul F, Prickett Todd D, Deniger Drew C, Matus-Nicodemus Rodrigo, Parkhurst Maria R, Crystal Jessica S, Trebska-Mcgowan Kasia, Rosenberg Steven A |
| 216129 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses |
2015-11-04 |
10.1186/2051-1426-3-s2-p373 |
Srivastava Minu, Murriel Christopher, Yun Rui, Mayes Erin, Jie Hyun-Bae, Axelrod Fumiko, Xie Ming-Hong, Bentley Trevor, Cancilla Belinda, Tam Raymond, O'Young Gilbert, Kapoun Ann, Lewicki John, Hoey Tim, Gurney Austin, Inkyung Park Angie |
